Form 4: IRADIMED Director Converts RSUs to Common Stock

IRADIMED Director Hilda Scharen-Guivel converted 1,767 restricted stock units into common stock, increasing her direct beneficial ownership to 6,496 shares.

Summary

• Hilda Frederique Scharen-Guivel, a Director of IRADIMED CORP (IRMD), acquired 1,767 shares of common stock on October 14, 2025.
• This acquisition resulted from the conversion of 1,767 restricted stock units (RSUs) into common stock on a one-for-one basis.
• Following this transaction, Ms. Scharen-Guivel directly beneficially owns 6,496 shares of IRADIMED CORP common stock.
• The restricted stock units were originally granted on October 14, 2022, under Iradimed Corporation's 2014 Equity Incentive Plan.
• These RSUs vest in three equal annual installments, with the first vesting occurring on October 14, 2023.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it reflects a director increasing their direct ownership in the company through a pre-scheduled vesting event, indicating continued alignment with shareholder interests. It is a routine, expected transaction with no negative implications.

Positives

• The transaction represents a director increasing their direct beneficial ownership in the company, which can be viewed as a positive sign of alignment with shareholder interests.
• The conversion of restricted stock units into common stock is a pre-scheduled vesting event, indicating the successful progression of the company's equity incentive plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This filing details a routine insider transaction related to an equity incentive plan. It does not provide information directly related to broader industry trends or competitive landscape, but rather reflects standard compensation and ownership practices for corporate directors.

Stakeholder Impact

• Shareholders: May view the director's increased direct ownership as a positive indicator of management's commitment and alignment with long-term company performance.

Next Steps

• Future equal annual installments of the remaining restricted stock units will vest on subsequent October 14th dates until fully vested.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled vesting and conversion of restricted stock units for a director. Such transactions are generally expected and do not typically provide new fundamental information that would warrant a change in investment recommendation. While the increased direct ownership by a director is a minor positive for alignment, it is not a significant catalyst for a 'buy' or 'sell' decision based solely on this filing. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive operational or financial news.

Keywords

IRMD, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Director Ownership, Equity Incentive Plan, Beneficial Ownership